Plant made pharmaceuticals, or PMPs, are proteins that are expressed in plants; that the plants would not ordinarily produce. Competing technologies rely upon expensive and complex bioreactors for the expression of recombinant proteins. When producing a plant made protein, the bioreactor is the plant itself, this offers the potential to significantly reduce the capital costs required for the commercialization of therapeutic proteins, and also eliminates some of the concerns surrounding utilizing animal based components that are used in competing technology.